Analysts’ Updated EPS Estimates for May 5th (ADCT, ADEA, ALNY, AMGN, AV, AVNW, BLZE, BMRC, BMRN, BRBY)

Analysts’ updated eps estimates for Tuesday, May 5th:

ADC Therapeutics (NYSE:ADCT) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $8.00 target price on the stock.

ADC Therapeutics (NYSE:ADCT) had its outperform rating reiterated by analysts at Royal Bank Of Canada. The firm currently has a $6.00 target price on the stock.

Adeia (NASDAQ:ADEA) had its buy rating reiterated by analysts at Rosenblatt Securities. Rosenblatt Securities currently has a $40.00 price target on the stock.

Alnylam Pharmaceuticals (NASDAQ:ALNY) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $510.00 target price on the stock.

Amgen (NASDAQ:AMGN) had its hold rating reiterated by analysts at Erste Group Bank AG.

Aviva (LON:AV) was downgraded by analysts at Jefferies Financial Group Inc. to a hold rating. Jefferies Financial Group Inc. currently has GBX 637 price target on the stock.

Aviat Networks (NASDAQ:AVNW) had its market perform rating reiterated by analysts at Northland Securities. They currently have a $20.00 target price on the stock.

Backblaze (NASDAQ:BLZE) had its market outperform rating reaffirmed by analysts at Citizens Jmp. Citizens Jmp currently has a $8.00 target price on the stock.

Bank of Marin Bancorp (NASDAQ:BMRC) had its equal weight rating reiterated by analysts at Stephens. They currently have a $26.00 target price on the stock.

BioMarin Pharmaceutical (NASDAQ:BMRN) had its sector perform rating reaffirmed by analysts at Royal Bank Of Canada. The firm currently has a $66.00 target price on the stock.

BioMarin Pharmaceutical (NASDAQ:BMRN) had its neutral rating reissued by analysts at HC Wainwright. They currently have a $55.00 price target on the stock.

Burberry Group (LON:BRBY) was downgraded by analysts at Berenberg Bank to a hold rating. The firm currently has GBX 1,080 target price on the stock.

Barratt Redrow (LON:BTRW) had its hold rating reaffirmed by analysts at Jefferies Financial Group Inc.. Jefferies Financial Group Inc. currently has a GBX 289 target price on the stock.

Anheuser-Busch InBev SA/NV (NYSE:BUD) had its buy rating reaffirmed by analysts at Royal Bank Of Canada.

Anheuser-Busch InBev SA/NV (NYSE:BUD) had its buy rating reiterated by analysts at Barclays PLC.

Anheuser-Busch InBev SA/NV (NYSE:BUD) had its buy rating reaffirmed by analysts at Jefferies Financial Group Inc..

Anheuser-Busch InBev SA/NV (NYSE:BUD) had its buy rating reissued by analysts at JPMorgan Chase & Co..

Bellway (LON:BWY) had its buy rating reiterated by analysts at Jefferies Financial Group Inc.. Jefferies Financial Group Inc. currently has a GBX 2,394 price target on the stock.

Perspective Therapeutics (NYSEAMERICAN:CATX) had its outperform rating reaffirmed by analysts at Wedbush. Wedbush currently has a $11.00 target price on the stock.

Coca-Cola HBC (LON:CCH) had its buy rating reiterated by analysts at UBS Group AG. UBS Group AG currently has a GBX 4,900 price target on the stock.

Cogent Communications (NASDAQ:CCOI) had its neutral rating reiterated by analysts at JPMorgan Chase & Co.. They currently have a $22.00 target price on the stock.

Compass Group (LON:CPG) had its buy rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.

Crescent Energy (NYSE:CRGY) had its overweight rating reaffirmed by analysts at Stephens. Stephens currently has a $18.00 price target on the stock.

Crest Nicholson (LON:CRST) had its buy rating reissued by analysts at Jefferies Financial Group Inc.. They currently have a GBX 112 price target on the stock.

Chevron (NYSE:CVX) had its outperform rating reiterated by analysts at Royal Bank Of Canada. The firm currently has a $220.00 price target on the stock.

Diageo (LON:DGE) had its neutral rating reiterated by analysts at UBS Group AG. UBS Group AG currently has a GBX 1,600 target price on the stock.

Diageo (LON:DGE) had its buy rating reissued by analysts at Deutsche Bank Aktiengesellschaft. The firm currently has a GBX 1,650 target price on the stock.

Distribution Solutions Group (NASDAQ:DSGR) had its overweight rating reissued by analysts at Stephens. Stephens currently has a $36.00 price target on the stock.

Duolingo (NASDAQ:DUOL) had its buy rating reaffirmed by analysts at Needham & Company LLC. They currently have a $145.00 target price on the stock.

GrafTech International (NYSE:EAF) had its sector perform rating reissued by analysts at Royal Bank Of Canada. The firm currently has a $10.00 price target on the stock.

EverQuote (NASDAQ:EVER) had its buy rating reaffirmed by analysts at Needham & Company LLC. The firm currently has a $25.00 target price on the stock.

Fabrinet (NYSE:FN) had its buy rating reiterated by analysts at Needham & Company LLC. They currently have a $800.00 target price on the stock.

HSBC (LON:HSBA) had its neutral rating reiterated by analysts at UBS Group AG. UBS Group AG currently has a GBX 1,419 target price on the stock.

HSBC (LON:HSBA) had its hold rating reiterated by analysts at Jefferies Financial Group Inc.. Jefferies Financial Group Inc. currently has a GBX 1,120 target price on the stock.

International Consolidated Airlines Group (LON:IAG) had its sell rating reaffirmed by analysts at UBS Group AG. They currently have a GBX 355 price target on the stock.

InterContinental Hotels Group (LON:IHG) had its neutral rating reiterated by analysts at UBS Group AG. They currently have a GBX 150 target price on the stock.

Inspire Medical Systems (NYSE:INSP) had its neutral rating reaffirmed by analysts at Bank of America Corporation. The firm currently has a $53.00 target price on the stock.

JD Sports Fashion (LON:JD) had its neutral rating reissued by analysts at UBS Group AG. They currently have a GBX 94 price target on the stock.

James River Group (NASDAQ:JRVR) had its market perform rating reissued by analysts at Citizens Jmp.

Kosmos Energy (LON:KOS) had its buy rating reaffirmed by analysts at Jefferies Financial Group Inc.. They currently have a GBX 210 price target on the stock.

Legal & General Group (LON:LGEN) was downgraded by analysts at Jefferies Financial Group Inc. to an underperform rating. They currently have GBX 185 target price on the stock.

Eli Lilly and Company (NYSE:LLY) had its buy rating reaffirmed by analysts at Guggenheim. They currently have a $1,183.00 price target on the stock.

Light Science Technologies (LON:LST) had its house stock rating reissued by analysts at Shore Capital Group Ltd. Shore Capital Group Ltd currently has a GBX 4.60 price target on the stock.

M&G (LON:MNG) had its neutral rating reissued by analysts at UBS Group AG. UBS Group AG currently has a GBX 300 price target on the stock.

ServiceNow (NYSE:NOW) had its outperform rating reissued by analysts at Royal Bank Of Canada. The firm currently has a $121.00 price target on the stock.

ServiceNow (NYSE:NOW) had its buy rating reaffirmed by analysts at Needham & Company LLC. Needham & Company LLC currently has a $115.00 target price on the stock.

ServiceNow (NYSE:NOW) had its market outperform rating reiterated by analysts at Citizens Jmp. They currently have a $157.00 target price on the stock.

Nuvation Bio (NYSE:NUVB) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $17.00 target price on the stock.

Nuvation Bio (NYSE:NUVB) had its outperform rating reaffirmed by analysts at Wedbush. The firm currently has a $11.00 target price on the stock.

Nuvation Bio (NYSE:NUVB) had its outperform rating reissued by analysts at Royal Bank Of Canada. The firm currently has a $20.00 target price on the stock.

NatWest Group (LON:NWG) had its buy rating reissued by analysts at Deutsche Bank Aktiengesellschaft. They currently have a GBX 840 target price on the stock.

NatWest Group (LON:NWG) had its sector perform rating reiterated by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a GBX 725 target price on the stock.

onsemi (NASDAQ:ON) had its hold rating reiterated by analysts at Truist Financial Corporation. They currently have a $101.00 price target on the stock, up from their previous price target of $66.00.

Orchid Island Capital (NYSE:ORC) was downgraded by analysts at Wall Street Zen from a hold rating to a sell rating.

Palantir Technologies (NASDAQ:PLTR) had its underperform rating reissued by analysts at Royal Bank Of Canada. They currently have a $90.00 target price on the stock.

Palantir Technologies (NASDAQ:PLTR) had its outperform rating reissued by analysts at Wedbush. Wedbush currently has a $230.00 price target on the stock.

Pearson (LON:PSON) had its hold rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft. Deutsche Bank Aktiengesellschaft currently has a GBX 1,033 target price on the stock.

PTC (NASDAQ:PTC) had its buy rating reissued by analysts at Rosenblatt Securities. The firm currently has a $190.00 price target on the stock.

Portillo’s (NASDAQ:PTLO) had its equal weight rating reiterated by analysts at Stephens. They currently have a $6.00 target price on the stock.

PayPal (NASDAQ:PYPL) had its hold rating reissued by analysts at Needham & Company LLC.

Q32 Bio (NASDAQ:QTTB) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $13.00 target price on the stock.

RB Global (NYSE:RBA) (TSE:RBA) had its equal weight rating reaffirmed by analysts at Stephens. They currently have a $96.00 target price on the stock.

Rightmove (LON:RMV) had its neutral rating reaffirmed by analysts at UBS Group AG. They currently have a GBX 481 price target on the stock.

Rotork (LON:ROR) had its buy rating reissued by analysts at Deutsche Bank Aktiengesellschaft. They currently have a GBX 400 target price on the stock.

Repay (NASDAQ:RPAY) was downgraded by analysts at Stephens from an overweight rating to an equal weight rating. Stephens currently has $3.75 target price on the stock, down from their previous target price of $7.00.

Red River Bancshares (NASDAQ:RRBI) was downgraded by analysts at Stephens from an overweight rating to an equal weight rating. They currently have $94.00 price target on the stock.

SBA Communications (NASDAQ:SBAC) had its buy rating reiterated by analysts at Truist Financial Corporation. Truist Financial Corporation currently has a $248.00 price target on the stock, up from their previous price target of $247.00.

Shell (LON:SHEL) had its neutral rating reaffirmed by analysts at UBS Group AG. UBS Group AG currently has a GBX 3,850 price target on the stock.

Shell (NYSE:SHEL) had its hold rating reaffirmed by analysts at Erste Group Bank AG.

Smith & Nephew (LON:SN) had its neutral rating reissued by analysts at UBS Group AG. They currently have a GBX 1,300 price target on the stock.

Sonos (NASDAQ:SONO) had its buy rating reissued by analysts at Rosenblatt Securities. They currently have a $21.00 target price on the stock.

Stagwell (NASDAQ:STGW) had its buy rating reiterated by analysts at Rosenblatt Securities. They currently have a $9.00 target price on the stock.

Trustpilot Group (LON:TRST) had its buy rating reiterated by analysts at UBS Group AG. They currently have a GBX 410 price target on the stock.

V2X (NYSE:VVX) had its buy rating reaffirmed by analysts at BTIG Research. The firm currently has a $90.00 target price on the stock.

Verizon Communications (NYSE:VZ) had its hold rating reiterated by analysts at Erste Group Bank AG.

ExxonMobil (NYSE:XOM) had its sector perform rating reissued by analysts at Royal Bank Of Canada. They currently have a $180.00 price target on the stock.

Receive News & Ratings for ADC Therapeutics SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ADC Therapeutics SA and related companies with MarketBeat.com's FREE daily email newsletter.